Tirzepatide (Oral)
Dual-action GLP-1 — in a daily tablet
Oral tirzepatide tablets bring dual GIP/GLP-1 appetite control to a needle-free daily routine — tirzepatide, a dual GIP/GLP-1 molecule studied extensively in clinical trials, prescribed online.
Overview
Oral Tirzepatide tablets deliver dual-action GIP/GLP-1 therapy in a convenient, needle-free daily tablet — for patients who want strong appetite control and fewer cravings without an injection.
How oral tirzepatide works
Dual GIP + GLP-1
Targets two metabolic pathways for strong appetite control.
Curbs cravings
Reduces hunger and increases fullness after meals.
Daily & needle-free
Brings a powerful approach to one simple tablet a day.
At a glance — technical specifications
| Active ingredient | Tirzepatide |
|---|---|
| Drug class | Dual GIP & GLP-1 receptor agonist (twincretin) |
| What it does | Strong appetite control via two pathways; supports weight loss — needle-free |
| How it works | Activates both GIP and GLP-1 receptors to reduce hunger and increase fullness |
| Form | Oral tablet |
| Administration | Once daily as directed by your provider |
| Dose range | 5 mg → 20 mg (gradual titration) |
| Onset | Appetite changes often within the first few weeks; full effect builds over months |
| FDA status | Compounded — not FDA-approved. No oral tirzepatide product is FDA-approved; prepared by a state-licensed U.S. compounding pharmacy after provider review |
| Prescription | Required — issued after licensed provider review |
| Storage | Store at room temperature, away from moisture |
Key benefits
The science
Average body-weight reduction at the 15 mg dose over 72 weeks in the SURMOUNT-1 trial of injectable tirzepatide.* Oral tirzepatide is a compounded formulation and has not been FDA-approved or separately studied. Individual results vary.
FDA status
What's included with Mediclab
- Review by a licensed U.S. provider (all 50 states)
- Personalized treatment plan & dosing
- Ongoing follow-up, tracking & refills
- Free, discreet shipping — HSA/FSA eligible
Safety & side effects
*SURMOUNT-1 clinical trial (injectable tirzepatide). Compounded medications are prepared by a licensed pharmacy and are not FDA-approved or reviewed for safety, effectiveness, or quality. Prescription required; available only after provider review and approval. This information is for educational purposes only and is not medical advice. Individual results vary.
Free shipping
Easy return
Safe checkout